Year |
Citation |
Score |
2019 |
Perumal V, Sivakumar PM, Zarrabi A, Muthupandian S, Vijayaraghavalu S, Sahoo K, Das A, Das S, Payyappilly SS, Das S. Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis. Journal of Photochemistry and Photobiology. B, Biology. 199: 111630. PMID 31610429 DOI: 10.1016/J.Jphotobiol.2019.111630 |
0.313 |
|
2017 |
Sahoo K, Karumuri S, Hikkaduwa Koralege RS, Flynn NH, Hartson S, Liu J, Ramsey JD, Kalkan K, Pope C, Ranjan A. Molecular and biocompatibility characterization of red blood cell membrane targeted and cell penetrating peptide-modified polymeric nanoparticles. Molecular Pharmaceutics. PMID 28505457 DOI: 10.1021/Acs.Molpharmaceut.7B00053 |
0.301 |
|
2014 |
Yadav VR, Hussain A, Sahoo K, Awasthi V. Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA. The Journal of Pharmacology and Experimental Therapeutics. 351: 413-22. PMID 25204337 DOI: 10.1124/Jpet.114.217331 |
0.576 |
|
2013 |
Yadav VR, Sahoo K, Awasthi V. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. British Journal of Pharmacology. 170: 1436-48. PMID 24102070 DOI: 10.1111/Bph.12406 |
0.647 |
|
2013 |
Yadav VR, Sahoo K, Roberts PR, Awasthi V. Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival. The Journal of Pharmacology and Experimental Therapeutics. 347: 346-56. PMID 23995597 DOI: 10.1124/Jpet.113.208009 |
0.621 |
|
2013 |
Yadav VR, Sahoo K, Awasthi V. Abstract 4866: CLEFMA induces apoptosis and downregulates inflammatory markers in lung cancer model. Cancer Research. 73: 4866-4866. DOI: 10.1158/1538-7445.Am2013-4866 |
0.686 |
|
2013 |
Sahoo KK, Yadav VR, Awasthi V. Abstract 3286: CLEFMA synergizes with celecoxib in suppression of lung cancer cell growth. Cancer Research. 73: 3286-3286. DOI: 10.1158/1538-7445.Am2013-3286 |
0.684 |
|
2012 |
Lagisetty P, Subramaniam D, Sahoo K, Anant S, Awasthi V. Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH). Chemical Biology & Drug Design. 79: 194-201. PMID 22107757 DOI: 10.1111/J.1747-0285.2011.01271.X |
0.623 |
|
2012 |
Sahoo K, Dozmorov MG, Anant S, Awasthi V. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress. Investigational New Drugs. 30: 558-67. PMID 21181232 DOI: 10.1007/S10637-010-9610-4 |
0.667 |
|
2012 |
Sahoo KK, Yadav VR, Awasthi V. Abstract 4887: Curcuminoid CLEFMA induces autophagy-associated apoptosis in lung cancer Cancer Research. 72: 4887-4887. DOI: 10.1158/1538-7445.Am2012-4887 |
0.685 |
|
2012 |
Yadav VR, Sahoo KK, Awasthi V. Abstract 256: Involvement of ERK and ROS in CLEFMA-induced apoptosis in lung cancer cells Cancer Research. 72: 256-256. DOI: 10.1158/1538-7445.Am2012-256 |
0.677 |
|
2011 |
Pathuri G, Sahoo K, Awasthi V, Gali H. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats. Nuclear Medicine Communications. 32: 908-12. PMID 21876402 DOI: 10.1097/Mnm.0B013E32834A6Db6 |
0.543 |
|
2011 |
Agashe H, Lagisetty P, Sahoo K, Bourne D, Grady B, Awasthi V. Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model. Journal of Nanoparticle Research : An Interdisciplinary Forum For Nanoscale Science and Technology. 13: 2609-2623. PMID 21779150 DOI: 10.1007/S11051-010-0154-5 |
0.628 |
|
2011 |
Agashe H, Sahoo K, Lagisetty P, Awasthi V. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids and Surfaces. B, Biointerfaces. 84: 329-37. PMID 21315563 DOI: 10.1016/J.Colsurfb.2011.01.023 |
0.67 |
|
2010 |
Pathuri G, Sahoo K, Awasthi V, Gali H. Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression. Bioorganic & Medicinal Chemistry Letters. 20: 5969-72. PMID 20829039 DOI: 10.1016/J.Bmcl.2010.08.082 |
0.577 |
|
2010 |
Lagisetty P, Vilekar P, Sahoo K, Anant S, Awasthi V. CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones. Bioorganic & Medicinal Chemistry. 18: 6109-20. PMID 20638855 DOI: 10.1016/J.Bmc.2010.06.055 |
0.678 |
|
2010 |
Lagisetty P, Agashe H, Sahoo K, Awasthi V. Tc-99m-labeled novel antiproliferative curcuminoid Nuclear Medicine and Biology. 37: 720-721. DOI: 10.1016/J.Nucmedbio.2010.04.095 |
0.554 |
|
Show low-probability matches. |